Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C16H14O5 |
| Molecular Weight | 286.2794 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OC1=CC=C2[C@H]3C4=CC(O)=C(O)C=C4C[C@@]3(O)COC2=C1
InChI
InChIKey=UWHUTZOCTZJUKC-JKSUJKDBSA-N
InChI=1S/C16H14O5/c17-9-1-2-10-14(4-9)21-7-16(20)6-8-3-12(18)13(19)5-11(8)15(10)16/h1-5,15,17-20H,6-7H2/t15-,16+/m0/s1
| Molecular Formula | C16H14O5 |
| Molecular Weight | 286.2794 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Brazilin isolated from Caesalpinia sappan has long been known as a natural red pigment. Brazilin is the safe natural compound having the potential to develop as a medicinal compound with application in food, beverage, cosmetics and pharmaceutical industries. It was shown, that brazilin exerts protective effects against renal ischemia-reperfusion injury by inhibiting the NF-κB signaling pathway. In addition, was revealed, that this compound prevented hyperglycemia, renal fibrosis, and inflammation, thus ameliorating renal functional decline in diabetic mice and may be a useful treatment for diabetic nephropathy. Brazilin isolated from H. brasiletto exhibited a moderate antiproliferative activity on the human non-cancer cell line, at the same time demonstrated to have antiproliferative activity against human cancer cell lines, and thus can be a potential source of anticancer agents.
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: map04064 Sources: https://www.ncbi.nlm.nih.gov/pubmed/27247107 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Preventing | Unknown Approved UseUnknown |
|||
| Preventing | Unknown Approved UseUnknown |
|||
| Primary | Unknown Approved UseUnknown |
|||
| Primary | Unknown Approved UseUnknown |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Antiproliferative activity of Haematoxylum brasiletto H. Karst. | 2017-07 |
|
| Brazilin from Caesalpinia sappan heartwood and its pharmacological activities: A review. | 2015-06 |
|
| Brazilin Limits Inflammatory Responses through Induction of Prosurvival Autophagy in Rheumatoid Fibroblast-Like Synoviocytes. | 2015 |
|
| Identification of HIV-1 integrase inhibitors based on a four-point pharmacophore. | 1998-11 |
|
| Inhibition of human immunodeficiency virus integrase by bis-catechols. | 1995-02 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/27247107
Treatment with brazilin (30 mg/kg, administered intravenously at 30 min prior to ischemia) led to the reversal of renal ischemia-reperfusion (I/R)-induced changes in serum creatinine (Scr) and blood urea nitrogen (BUN) levels, and also attenuated the histopathological damage induced by I/R.
db/db mice: brazilin (40 mg/kg/day i.p.)
Route of Administration:
Other
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/28972932
Brazilin was used to inhibit Zn2+-mediated Aβ aggregation and alleviate its cytotoxicity. The binding properties of brazilin and Zn2+ were first probed using Fourier transform infrared (FTIR) spectroscopy and isothermal titration calorimetry (ITC) assays. Both the FTIR and ITC results have shown that brazilin is able to bind Zn2+ in a physiologically suitable range of concentrations. The dissociation constant (Kd) between brazilin and Zn2+ was about 46.0±6.8μM, which makes brazilin a potential drug model for the chelation of free Zn2+. Moreover, the higher affinity of brazilin for Aβ42 (Kd=2.5±1.6μM) than that of Zn2+ (Kd=6.2±0. 9μM), enables brazilin to sequester Zn2+ from the Aβ42-Zn2+ complex.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 19:30:04 GMT 2025
by
admin
on
Mon Mar 31 19:30:04 GMT 2025
|
| Record UNII |
FZ39SW1K10
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
BRAZILIN
Created by
admin on Mon Mar 31 19:30:04 GMT 2025 , Edited by admin on Mon Mar 31 19:30:04 GMT 2025
|
PRIMARY | |||
|
3170
Created by
admin on Mon Mar 31 19:30:04 GMT 2025 , Edited by admin on Mon Mar 31 19:30:04 GMT 2025
|
PRIMARY | |||
|
FZ39SW1K10
Created by
admin on Mon Mar 31 19:30:04 GMT 2025 , Edited by admin on Mon Mar 31 19:30:04 GMT 2025
|
PRIMARY | |||
|
474-07-7
Created by
admin on Mon Mar 31 19:30:04 GMT 2025 , Edited by admin on Mon Mar 31 19:30:04 GMT 2025
|
PRIMARY | |||
|
DTXSID80883393
Created by
admin on Mon Mar 31 19:30:04 GMT 2025 , Edited by admin on Mon Mar 31 19:30:04 GMT 2025
|
PRIMARY | |||
|
C044362
Created by
admin on Mon Mar 31 19:30:04 GMT 2025 , Edited by admin on Mon Mar 31 19:30:04 GMT 2025
|
PRIMARY | |||
|
207-477-6
Created by
admin on Mon Mar 31 19:30:04 GMT 2025 , Edited by admin on Mon Mar 31 19:30:04 GMT 2025
|
PRIMARY | |||
|
56652
Created by
admin on Mon Mar 31 19:30:04 GMT 2025 , Edited by admin on Mon Mar 31 19:30:04 GMT 2025
|
PRIMARY | |||
|
m2642
Created by
admin on Mon Mar 31 19:30:04 GMT 2025 , Edited by admin on Mon Mar 31 19:30:04 GMT 2025
|
PRIMARY | Merck Index | ||
|
73384
Created by
admin on Mon Mar 31 19:30:04 GMT 2025 , Edited by admin on Mon Mar 31 19:30:04 GMT 2025
|
PRIMARY |